Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001170186 | SCV001332736 | likely benign | Cardiomyopathy | 2018-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001477210 | SCV001681440 | likely benign | Myofibrillar myopathy 4 | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001709707 | SCV001936969 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418600 | SCV002729109 | likely benign | Cardiovascular phenotype | 2021-04-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |